Literature DB >> 33993413

The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.

Julian Maier1, Marco Niello1, Deborah Rudin1, Lynette C Daws2,3, Harald H Sitte4.   

Abstract

Organic cation transporters 1-3 (OCT1-3, SLC22A1-3) and the plasma membrane monoamine transporter (PMAT, SLC29A4) play a major role in maintaining monoaminergic equilibrium in the central nervous system. With many psychoactive substances interacting with OCT1-3 and PMAT, a growing literature focuses on characterizing their properties via in vitro and in vivo studies. In vitro studies mainly aim at characterizing compounds as inhibitors or substrates of murine, rat, and human isoforms. The preponderance of studies has put emphasis on phenylalkylamine derivatives, but ketamine and opioids have also been investigated. Studies employing in vivo (knockout) models mostly concentrate on the interaction of psychoactive substances and OCT3, with an emphasis on stress and addiction, pharmacokinetics, and sensitization to psychoactive drugs. The results highlight the importance of OCT3 in the mechanism of action of psychoactive compounds. Concerning in vivo studies, a veritable research gap concerning OCT1, 2, and PMAT exists. This review provides an overview and summary of research conducted in this field of research.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Amphetamine; Ketamine; New psychoactive substances; Opioids; Stress-addiction axis

Mesh:

Substances:

Year:  2021        PMID: 33993413     DOI: 10.1007/164_2021_469

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  52 in total

Review 1.  Role of organic cation transporters (OCTs) in the brain.

Authors:  Thomas Couroussé; Sophie Gautron
Journal:  Pharmacol Ther       Date:  2014-09-22       Impact factor: 12.310

2.  Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.

Authors:  Nagisa Aoyama; Nagahide Takahashi; Kiyoyuki Kitaichi; Ryoko Ishihara; Shinichi Saito; Nobuhisa Maeno; Xiaofei Ji; Kenji Takagi; Yoshimoto Sekine; Masaomi Iyo; Mutsuo Harano; Tokutaro Komiyama; Mitsuhiko Yamada; Ichiro Sora; Hiroshi Ujike; Nakao Iwata; Toshiya Inada; Norio Ozaki
Journal:  Alcohol Clin Exp Res       Date:  2006-10       Impact factor: 3.455

3.  Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment.

Authors:  J L Barr; G L Forster
Journal:  Neuroscience       Date:  2011-03-21       Impact factor: 3.590

4.  Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.

Authors:  Ligong Chen; Bradley Pawlikowski; Avner Schlessinger; Swati S More; Doug Stryke; Susan J Johns; Michael A Portman; Eugene Chen; Thomas E Ferrin; Andrej Sali; Kathleen M Giacomini
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

5.  Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun.

Authors:  Nicole Baganz; Rebecca Horton; Kathryn Martin; Andrew Holmes; Lynette C Daws
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

6.  Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.

Authors:  Anne Amphoux; Vincent Vialou; Eva Drescher; Michael Brüss; Clotilde Mannoury La Cour; Catherine Rochat; Mark J Millan; Bruno Giros; Heinz Bönisch; Sophie Gautron
Journal:  Neuropharmacology       Date:  2006-03-31       Impact factor: 5.250

7.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

8.  Human organic cation transporter 2 (hOCT2): Inhibitor studies using S2-hOCT2 cells.

Authors:  Shoetsu Chiba; Toru Ikawa; Hiroshi Takeshita; Sanae Kanno; Tomonori Nagai; Meri Takada; Toshiji Mukai; Michael F Wempe
Journal:  Toxicology       Date:  2013-06-13       Impact factor: 4.221

9.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Authors:  Mei Cui; Radha Aras; Whitney V Christian; Phillip M Rappold; Mamata Hatwar; Joseph Panza; Vernice Jackson-Lewis; Jonathan A Javitch; Nazzareno Ballatori; Serge Przedborski; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

10.  Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.

Authors:  Rheaclare Fraser-Spears; Anwen M Krause-Heuer; Mohamed Basiouny; Felix P Mayer; Retrouvailles Manishimwe; Naomi A Wyatt; Jeremy C Dobrowolski; Maxine P Roberts; Ivan Greguric; Naresh Kumar; Wouter Koek; Harald H Sitte; Paul D Callaghan; Benjamin H Fraser; Lynette C Daws
Journal:  Eur J Pharmacol       Date:  2018-10-25       Impact factor: 5.195

View more
  7 in total

Review 1.  Unique Chemistry, Intake, and Metabolism of Polyamines in the Central Nervous System (CNS) and Its Body.

Authors:  Julian Rieck; Serguei N Skatchkov; Christian Derst; Misty J Eaton; Rüdiger W Veh
Journal:  Biomolecules       Date:  2022-03-25

2.  MPP+-Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition.

Authors:  Tamara A M Mocking; Hubert J Sijben; Yimé W Vermeulen; Adriaan P IJzerman; Laura H Heitman
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

3.  Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.

Authors:  Thomas J F Angenoorth; Stevan Stankovic; Marco Niello; Marion Holy; Simon D Brandt; Harald H Sitte; Julian Maier
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 6.208

4.  High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish.

Authors:  Georgianna G Gould; Priscilla A Barba-Escobedo; Rebecca E Horton; Lynette C Daws
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

5.  Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools.

Authors:  Jasmin N Beaver; Brady L Weber; Matthew T Ford; Anna E Anello; Sarah K Kassis; T Lee Gilman
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

6.  Organic Cation Transporters in Psychiatric Disorders.

Authors:  Lynette C Daws
Journal:  Handb Exp Pharmacol       Date:  2021

7.  Role of Organic Cation Transporter 3 and Plasma Membrane Monoamine Transporter in the Rewarding Properties and Locomotor Sensitizing Effects of Amphetamine in Male andFemale Mice.

Authors:  Nikki J Clauss; Wouter Koek; Lynette C Daws
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.